NIH Beginning New Birth Defect Study; CBCD Looks Forward to Learning Results

FOR IMMEDIATE RELEASE
Houston, Texas, United States of America (Free-Press-Release.com) December 21, 2011 -- The Center for the Biology of Chronic Disease (CBCD) is excited to learn that the National Institute of Health (NIH) is beginning a new, large study using antibodies (proteins used by the immune system) to test a way to prevent birth defects. A common virus in the Herpes family of viruses known as the Cytomegalovirus (CMV) causes defects such as blindness and deafness in newborn infants.

According to Bill Rawlinson, senior medical virologist at the University of New South Wales, more babies are born with a CMV infection than Down Syndrome.

Cytomegalovirus antibodies worth $2.5 million are being donated to the NIH by Australian blood plasma group CSL. However, the study won’t be analyzed until sometime in 2016. The CBCD looks forward to the study’s conclusion and to learning their results.

To date, there is no vaccine against a Cytomegalovirus infection.

Up until today, prevention of a Cytomegalovirus infection has focused on avoiding exposure to saliva and urine. The Centers for Disease Control (CDC) recommends Washing hands often with soap and water for 15-20 seconds, especially after changing diapers, feeding a young child, wiping a young child’s nose or drool, or handling children’s toys.

People also should not share food, drinks, or eating utensils used by young children. They should not put a child’s pacifier in the mouth, share a toothbrush with a young child, and they should avoid contact with saliva when kissing a child. They should also clean toys, countertops, and other surfaces that come into contact with children’s urine or saliva.

At present, the CBCD believes a Cytomegalovirus infection may be improved and symptoms lessened by boosting the immune system with a CMV remedy that works against the sleeping (latent) Cytomegalovirus.

One CMV remedy that has scientifically been developed to boost the immune system against the latent Cytomegalovirus is Gene-Eden-VIR. The CBCD suggests trying this all natural, broad-spectrum, antiviral remedy.

Why?

The CBCD believes taking Gene-Eden-VIR makes sense. It goes beyond symptoms to the cause and helps lower the concentration of the latent CMV and within the body by boosting the natural immune system.

“The key to your health is to reduce the level of the chronic viruses in your body to harmless levels. There are no known medications or supplements that can completely eradicate these viruses, except in rare cases where your immune system recovers.” – Dr. Hanan Polansky

Gene-Eden-VIR is not a drug. It is not a cure. However, it is the first antiviral, natural, CMV remedy scientifically designed to boost the immune system and lower the numbers of the latent Cytomegalovirus in your body to symptom free levels.

Those who are considering taking it may have questions about how much it costs, whether it is safe, and whether it is effective.

Gene-Eden-VIR is an extremely safe CMV remedy. To date, in over three years of being on the market, no side effects have been reported by Gene-Eden’s users. Each capsule contains a patented formula of five all natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract. In addition, each bottle is GMP Certified.

(If a product is GMP Certified it means that the product is keeping good manufacturing practices as outlined by the Food and Drug Administration [FDA].)

Gene-Eden-VIR is highly effective against latent viruses; each ingredient was selected through a scientific approach. PolyDNA scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world in order to identify the safest, most effective natural ingredients that target the latent (chronic) Herpes Simplex family of viruses which includes the Cytomegalovirus.

Scientific papers on the ingredients of Gene-Eden-VIR can be easily accessed on pubmed.gov, and a select few can be found on the Gene-Eden website at Gene-Eden.com.

Gene-Eden-VIR is sold exclusively online through the Gene-Eden website. This lowers operating costs and allows savings to be passed on to Gene-Eden’s users!

Each bottle of Gene-Eden-VIR (a one month’s supply) costs just $34.99.

The CBCD believes that a healthy and active immune system can provide sufferers of a Cytomegalovirus infection with the energy to take on life’s challenges.

To learn more about Gene-Eden-VIR, the only CMV remedy on the market today that helps the body maintain low concentrations of the latent Cytomegalovirus, that is scientifically backed by published material, and that was developed without the use of animal test subjects, please visit http://www.Gene-Eden.com.

# # #

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

birth defects     CMV remedy     cytomegalovirus     Cytomegalovirus infection     gene-eden-vir     Latent Virus     nih     virus